Ophthalmology

By DDNews Staff

A hope for fewer injections

Roche's faricimab injected every 16 weeks proves non-inferior to aflibercept injected every eight weeks in patients with “wet” age-related macular degeneration
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

July/August 2022 : Volume 18 : Issue 7

Latest Issue  

• Volume 18 • Issue 7 • July/August 2022

July/August 2022

July/August 2022 Issue